Your browser doesn't support javascript.
loading
Identification of factors associated with sarcopenic obesity development: Literature review and expert panel voting.
Pinel, A; Guillet, C; Capel, F; Pouget, M; De Antonio, M; Pereira, B; Topinkova, E; Eglseer, D; Barazzoni, R; Cruz-Jentoft, A J; Schoufour, J D; Weijs, P J M; Boirie, Y.
Afiliação
  • Pinel A; University of Clermont Auvergne, Human Nutrition Unit, INRAe, CRNH Auvergne, Clermont-Ferrand, France. Electronic address: alexandre.pinel@uca.fr.
  • Guillet C; University of Clermont Auvergne, Human Nutrition Unit, INRAe, CRNH Auvergne, Clermont-Ferrand, France. Electronic address: christelle.guillet@uca.fr.
  • Capel F; University of Clermont Auvergne, Human Nutrition Unit, INRAe, CRNH Auvergne, Clermont-Ferrand, France.
  • Pouget M; CHU Clermont-Ferrand, Clinical Nutrition Department, Clermont-Ferrand, France. Electronic address: mpouget@chu-clermontferrand.fr.
  • De Antonio M; CHU Clermont-Ferrand, Biostatistics Unit, Clermont-Ferrand, France. Electronic address: mdeantonio@chu-clermontferrand.fr.
  • Pereira B; CHU Clermont-Ferrand, Biostatistics Unit, Clermont-Ferrand, France. Electronic address: bpereira@chu-clermontferrand.fr.
  • Topinkova E; Department of Geriatrics, First Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic. Electronic address: eva.topinkova@vfn.cz.
  • Eglseer D; Institute of Nursing Science, Medical University of Graz, Graz, Austria. Electronic address: doris.eglseer@medunigraz.at.
  • Barazzoni R; Department of Medical, Surgical and Health Sciences, University of Trieste, Italy. Electronic address: barazzon@units.it.
  • Cruz-Jentoft AJ; Hospital Universitario Ramón y Cajal (IRYCIS), Madrid, Spain. Electronic address: alfonsojose.cruz@salud.madrid.org.
  • Schoufour JD; Center of Expertise Urban Vitality, Amsterdam University of Applied Sciences, Amsterdam, the Netherlands. Electronic address: j.d.schoufour@hva.nl.
  • Weijs PJM; Center of Expertise Urban Vitality, Amsterdam University of Applied Sciences, Amsterdam, the Netherlands; Amsterdam University Medical Centers, Amsterdam Public Health Institute, VU University, Department of Nutrition and Dietetics, Amsterdam, the Netherlands. Electronic address: p.j.m.weijs@hva.nl.
  • Boirie Y; University of Clermont Auvergne, Human Nutrition Unit, INRAe, CRNH Auvergne, Clermont-Ferrand, France; CHU Clermont-Ferrand, Clinical Nutrition Department, Clermont-Ferrand, France. Electronic address: yves.boirie@uca.fr.
Clin Nutr ; 43(6): 1414-1424, 2024 Jun.
Article em En | MEDLINE | ID: mdl-38701709
ABSTRACT
Sarcopenic obesity (SO) is defined as the combination of excess fat mass (obesity) and low skeletal muscle mass and function (sarcopenia). The identification and classification of factors related to SO would favor better prevention and diagnosis. The present article aimed to (i) define a list of factors related with SO based on literature analysis, (ii) identify clinical conditions linked with SO development from literature search and (iii) evaluate their relevance and the potential research gaps by consulting an expert panel. From 4746 articles screened, 240 articles were selected for extraction of the factors associated with SO. Factors were classified according to their frequency in the literature. Clinical conditions were also recorded. Then, they were evaluated by a panel of expert for evaluation of their relevance in SO development. Experts also suggested additional factors. Thirty-nine unique factors were extracted from the papers and additional eleven factors suggested by a panel of experts in the SO field. The frequency in the literature showed insulin resistance, dyslipidemia, lack of exercise training, inflammation and hypertension as the most frequent factors associated with SO whereas experts ranked low spontaneous physical activity, protein and energy intakes, low exercise training and aging as the most important. Although literature and expert panel presented some differences, this first list of associated factors could help to identify patients at risk of SO. Further work is needed to confirm the contribution of factors associated with SO among the population overtime or in randomized controlled trials to demonstrate causality.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Sarcopenia / Obesidade Limite: Humans Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Sarcopenia / Obesidade Limite: Humans Idioma: En Ano de publicação: 2024 Tipo de documento: Article